GlassScriptPrepare for your visit
Nathan Daniel Speer
Pediatrics · Abilene, TX · NPI 1295120418
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$426.24
in general payments reported to CMS, 2019-2025 · $20.43 in 2025
The $20.43 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Who reported paying
General payments only, top 6 by amount.
- Corium, LLC $216.88
- Ironshore Pharmaceuticals INC. $71.96
- Glaxosmithkline, LLC. $34.39
- Merck Sharp & Dohme LLC $33.88
- Astrazeneca Pharmaceuticals LP $26.66
- Sobi, INC $21.98
Drugs and devices associated with these payments
Azstarys Flumist Quadrivalent Synagis Prevnar 20 Trumenba Comirnaty Vaxneuvance Rotateq Vaqta Rotarix Pediarix Bexsero
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Nathan Speer listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/4280197/nathan-daniel-speer